HealthcareServices

Diagnostics-As-A-Service Market to Reach $11.5 Billion by 2029, Growing at a CAGR of 20.8%

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Diagnostics-As-A-Service Industry In 2025?

The diagnostics-as-a-service market has experienced rapid expansion in recent years. Its size is projected to increase from $4.45 billion in 2024 to $5.40 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 21.2%. This historical growth can be linked to several factors, including the emergence of digital healthcare, a greater need for early disease identification, the increasing use of cloud-based solutions, escalating healthcare expenses necessitating efficient options, and an elevated requirement for quicker, more precise diagnostics.

The diagnostics-as-a-service market size is anticipated to experience substantial growth in the coming years, expanding to $11.50 billion by 2029, achieving a compound annual growth rate (CAGR) of 20.8%. This expansion during the forecast period is driven by factors such as the rising prevalence of chronic conditions, the progression of personalized medicine, an increasing demand for remote and home-based testing options, a heightened focus on cost-efficient diagnostic methods, and supportive regulatory frameworks for digital healthcare solutions. Major developments expected in the forecast period include the integration of AI-driven diagnostics, the adoption of cloud-based platforms, comprehensive multi-omics solutions, remote and in-home testing capabilities, real-time analytics with digital reporting, blockchain-enabled data security measures, and personalized, patient-centric diagnostic services.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28193&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Diagnostics-As-A-Service Industry?

The expanding occurrence of chronic illnesses is anticipated to fuel the expansion of the diagnostics-as-a-service market. These are enduring health conditions that manifest gradually and necessitate ongoing medical attention. A major factor contributing to the increasing incidence of chronic diseases is sedentary lifestyles, where extended periods of sitting and insufficient physical activity heighten the risk of conditions such as heart disease and diabetes. Diagnostics-as-a-service facilitates the diagnosis of chronic diseases through cloud-based testing and analytical capabilities, making the oversight of long-term conditions more straightforward. This service enhances patient care by providing prompt data, minimizing hospital visits, and boosting accessibility for individuals with continuous health requirements. For example, data from June 2024 by the National Health Service revealed that 3,615,330 individuals registered with a general practitioner in the UK were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, indicating an 18% increase from 3,065,825 cases in 2022. Consequently, the rising frequency of chronic diseases is a significant impetus for the growth of the diagnostics-as-a-service market. The rising acceptance of personalized medicine is expected to stimulate the growth of the diagnostics-as-a-service market. Personalized medicine involves a healthcare approach where treatment and prevention strategies are customized to an individual’s distinct genetic makeup, lifestyle, and surroundings. This increasing adoption is primarily due to breakthroughs in genomics, which allow for the accurate identification of genetic differences and the development of customized therapies for patients. Diagnostics-as-a-service improves personalized medicine by offering instant, cloud-based diagnostic services that facilitate quick and accurate patient evaluations. These services optimize data gathering and analysis, thereby supporting bespoke treatment plans and enhancing clinical judgments. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, stated that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a considerable rise from the 12 approved in 2022. Consequently, the increasing embrace of personalized medicine is propelling the expansion of the diagnostics-as-a-service market.

How Is The Diagnostics-As-A-Service Market Classified Into Different Segments?

The diagnostics-as-a-service market covered in this report is segmented as

1) By Component: Software, Services, Platforms

2) By Deployment Mode: Cloud-Based, On-Premises, Hybrid

3) By Application: Clinical Diagnostics, Imaging Diagnostics, Pathology, Genomics, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users

Subsegments:

1) By Software: Diagnostic Analytics Software, Clinical Decision Support Software, artificial intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools, Imaging And Visualization Software, Data Integration And Interoperability Software, Remote Monitoring And Reporting Software

2) By Services: Diagnostic Testing Services, Remote And Virtual Diagnostic Services, Cloud-Based Data Storage And Management, Consulting And Implementation Services, Training And Support Services, Maintenance And Upgradation Services

3) By Platforms: Cloud-based Diagnostic Platforms, On-Premise Diagnostic Platforms, Hybrid Deployment Platforms, Application Programming Interface (API) And Integration Platforms, Mobile Or Tele-Diagnostics Platforms, Data Exchange And Collaboration Platforms

What Trends Are Expected To Drive The Diagnostics-As-A-Service Market?

Leading companies in the diagnostics-as-a-service market are concentrating on developing patient-focused solutions, such as at-home lab testing services, to enhance accessibility and convenience. At-home lab testing services are diagnostic kits that enable individuals to collect samples at home and obtain test results without visiting a clinic. For instance, in June 2025, Amazon India, a US-based e-commerce company, partnered with Orange Health Labs, an India-based healthcare company, to launch Amazon Diagnostics, an at-home lab testing service under Amazon Medical. This service is available across six major cities, offering doorstep sample collection within 60 minutes and digital reports in as little as six hours, covering over 800 diagnostic tests. Integrated into the Amazon app, it allows customers to book, track, and access secure reports seamlessly. This initiative addresses critical gaps in India’s diagnostic landscape, including delays, accessibility, and quality, while fortifying Amazon’s vision of providing comprehensive healthcare services, encompassing pharmacy and clinics.

Who Are The Prominent Global Companies Shaping The Diagnostics-As-A-Service Market?

Major companies operating in the diagnostics-as-a-service market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Invitae Corporation, InHealth Group Limited, Canon Medical Systems Corporation, Freenome Holdings Inc., BioSerenity SAS, PathAI Inc., Butterfly Network Inc., Aidoc Medical Ltd., Owkin Inc., K Health Inc., and Probatix GmbH.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/diagnostics-as-a-service-global-market-report

How Do Regional Market Performances Compare Within The Diagnostics-As-A-Service Industry?

North America was the largest region in the diagnostics-as-a-service market in 2024. The regions covered in diagnostics-as-a-service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Diagnostics-As-A-Service Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28193&type=smp

Browse Through More Reports Similar to the Global Diagnostics-As-A-Service Market 2025, By The Business Research Company

Diagnostic Imaging Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-services-global-market-report

Remote Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/remote-diagnostics-global-market-report

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795